Home / BusinessMarketWatchBusinessMarketWatch·Jun 8, 2026·1 min readZealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trialThe drugmaker’s shares tumbled in Copenhagen after saying a fifth of users discontinued its weight-loss drug because of gastrointestinal issues.View original source — MarketWatch ↗ShareCopy linkShare on XShare on FacebookMore from BusinessAllAfricaBusinessJun 8, 2026 · 1 minKenya: President Ruto Launches Kenya-Benelux Chamber of Commerce in BrusselsAllAfricaBloombergBusinessJun 8, 2026 · 1 minApple’s Revamped AI Is a Long-Term Play in a Down PC, Mobile Phone MarketBloombergBloombergBusinessJun 8, 2026 · 1 minClean-Tech Venture Investors Face Concentration Risks in FundsBloomberg
AllAfricaBusinessJun 8, 2026 · 1 minKenya: President Ruto Launches Kenya-Benelux Chamber of Commerce in BrusselsAllAfrica
BloombergBusinessJun 8, 2026 · 1 minApple’s Revamped AI Is a Long-Term Play in a Down PC, Mobile Phone MarketBloomberg
BloombergBusinessJun 8, 2026 · 1 minClean-Tech Venture Investors Face Concentration Risks in FundsBloomberg